The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
CA 15-3: Uses and limitation as a biomarker for breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Self-citationBast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Structure and Function of the Cell Surface (Tethered) Mucins
Hattrup, C. L., & Gendler, S. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100659 · Cited by 779
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
Pisani, P., Bray, F., & Parkin, D. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.1571 · Cited by 730
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Hortobagyi, G. N., de la Garza Salazar, J., Pritchard, K., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H., Liu, M.-C., Martin, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586
KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.223 · Cited by 573
Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial
Del Turco, M. R. (1994) · JAMA · doi:10.1001/jama.1994.03510440053032 · Cited by 497
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
Duffy, M. J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059832 · Cited by 460
Self-citationClinical utility of cytokeratins as tumor markers
Barak, V., Goike, H., Panaretakis, K. W., & Einarsson, R. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.009 · Cited by 382
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
Molina, R., Barak, V., van Dalen, A., Duffy, M. J., Einarsson, R., Gion, M., Goike, H., Lamerz, R., Nap, M., Sölétormos, G., et al. (2005) · Tumor Biology · doi:10.1159/000089260 · Cited by 334
Self-citationComparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes, D. F., Zurawski, V. R., & Kufe, D. W. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1542 · Cited by 319
Benson, J. R., Jatoi, I., Keisch, M., Esteva, F. J., Makris, A., & Jordan, V. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60316-0 · Cited by 261
Cardoso, F., Bedard, P. L., Winer, E. P., Pagani, O., Senkus-Konefka, E., Fallowfield, L. J., Kyriakides, S., Costa, A., Cufer, T., Albain, K. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp235 · Cited by 241
The importance of MUC1 cellular localization in patients with breast carcinoma
Rahn, J. J., Dabbagh, L., Pasdar, M., & Hugh, J. C. (2001) · Cancer · Cited by 240
O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy
Burchell, J. M., Mungul, A., & Taylor-Papadimitriou, J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011331809881 · Cited by 221
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
Ebeling, F. G., Stieber, P., Untch, M., Nagel, D., Konecny, G. E., Schmitt, U. M., Fateh-Moghadam, A., & Seidel, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600248 · Cited by 215
Price, M. R., Rye, P. D., Petrakou, E., Murray, A., Brady, K., Imai, S., Haga, S., Kiyozuka, Y., Schol, D., Meulenbroek, M. F. A., et al. (1998) · Tumor Biology · doi:10.1159/000056500 · Cited by 213
Tumor Necrosis Factor-α Converting Enzyme/ADAM 17 Mediates MUC1 Shedding
Thathiah, A., Blobel, C. P., & Carson, D. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208326200 · Cited by 211
Human DF3/MUC1 carcinoma-associated protein functions as an oncogene
Li, Y., Liu, D. H., Chen, D., Kharbanda, S. M., & Kufe, D. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206732 · Cited by 205
Tumour marker measurements in the diagnosis and monitoring of breast cancer
Cheung, K. L., Graves, C. R. L., & Robertson, J. F. R. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0151 · Cited by 183
Predictive Markers in Breast and Other Cancers: A Review
Duffy, M. J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046227 · Cited by 174
Self-citationMUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., & Gendler, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206291 · Cited by 173
MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17
THATHIAH, A., & CARSON, D. D. (2004) · Biochemical Journal · doi:10.1042/bj20040513 · Cited by 169
Sturgeon, C. M., Hoffman, B. R., Chan, D. W., Ch'ng, S.-L., Hammond, E., Hayes, D. F., Liotta, L. A., Petricoin, E. F., Schmitt, M., Semmes, O. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.094144 · Cited by 166
MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1
Rahn, J. J., Chow, J., Horne, G., Mah, B. K., Emerman, J. T., Hoffman, P., & Hugh, J. C. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-3098-x · Cited by 159
Raina, D. B., Ahmad, R., Joshi, M. D., Li, Y., Wu, Z., Kawano, T., Vasir, B., Avigan, D., Kharbanda, S. M., & Kufe, D. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0854 · Cited by 153
Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Kataja, V. V., & Castiglione, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp114 · Cited by 135
MUC1 alters oncogenic events and transcription in human breast cancer cells
Hattrup, C. L., & Gendler, S. J. (2006) · Breast Cancer Research · doi:10.1186/bcr1515 · Cited by 117
Duffy, M. J., Duggan, C. R., Keane, R., Hill, A. D. K., McDermott, E. W. M., Crown, J. P., & O’Higgins, N. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.025288 · Cited by 116
Self-citationFollow-up of Patients with Early Breast Cancer
Hayes, D. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp067260 · Cited by 105
Ali, S. M., Carney, W. P., Esteva, F. J., Fornier, M. N., Harris, L. N., Köstler, W. J., Lotz, J., Lüftner, D., Pichon, M. F., & Lipton, A. (2008) · Cancer · doi:10.1002/cncr.23689 · Cited by 87
Molina, R., Auge, J. M., Fernández, J. M. E., Filella, X., Zanón, G., Pahisa, J., Farrus, B., Muñoz-Mateu, M., & Velasco, M. (2010) · Tumor Biology · doi:10.1007/s13277-010-0025-9 · Cited by 85
Kumpulainen, E., Keskikuru, R., & Johansson, R. T. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020514925143 · Cited by 80
Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game
Gion, M., Boracchi, P., Dittadi, R., Biganzoli, E. M., Peloso, L., Mione, R., Gatti, C., Paccagnella, A., & Marubini, E. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00426-9 · Cited by 73
Nicolini, A., Anselmi, L., Michelassi, C., & Carpi, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.515 · Cited by 66
Nicolini, A., Tartarelli, G., Carpi, A., Metelli, M. R., Ferrari, P., Anselmi, L., Conte, M., Berti, P., & Miccoli, P. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-269 · Cited by 63
izares, F. C. N., Sola, J. J., rez, M. P. E., Tovar, I., Heras, M. D. L., Salinas, J., afiel, R. P. N., & Nez, P. (2001) · Tumor Biology · doi:10.1159/000050627 · Cited by 50
Klee, G. G., & Schreiber, W. E. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1131-mggafm · Cited by 49
Carraway, K. L., Palau, V. E., & Carraway, C. A. C. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20612 · Cited by 34
Dixon, J. M., & Montgomery, D. (2008) · BMJ · doi:10.1136/bmj.39421.440799.be · Cited by 32
Cited by
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Tian, F., Zhang, S., Liu, C., Han, Z., Liu, Y., Deng, J., Li, Y., Wu, X., Cai, L., Qin, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22913-7 · Cited by 291
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers
Duffy, M. J. (2013) · Medical Principles and Practice · doi:10.1159/000338393 · Cited by 278
Self-citation
Metadata
- Authors
- Duffy, M. J., Evoy, D., & McDermott, E. W.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 411
- Issue
- 23-24
- Pages
- 1869-1874
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2053059448
- Cited by
- 371
- References
- 46
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.